Psychopharmacologic approaches to borderline syndromes

Compr Psychiatry. 1984 May-Jun;25(3):255-62. doi: 10.1016/0010-440x(84)90056-7.
No abstract available

Publication types

  • Review

MeSH terms

  • Anger / drug effects
  • Antidepressive Agents / therapeutic use
  • Antipsychotic Agents / therapeutic use
  • Anxiety / complications
  • Attention Deficit Disorder with Hyperactivity / drug therapy
  • Borderline Personality Disorder / complications
  • Borderline Personality Disorder / drug therapy*
  • Cognition Disorders / complications
  • Epilepsy, Temporal Lobe / drug therapy
  • Humans
  • Monoamine Oxidase Inhibitors / therapeutic use
  • Mood Disorders / complications
  • Neurocognitive Disorders / drug therapy
  • Personality Disorders / complications
  • Personality Disorders / drug therapy*
  • Schizophrenia / complications
  • Schizotypal Personality Disorder / diagnosis

Substances

  • Antidepressive Agents
  • Antipsychotic Agents
  • Monoamine Oxidase Inhibitors